Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intermediate-High Risk”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT02153580
What this trial is testing

Cellular Immunotherapy Following Chemotherapy in Treating Patients With Recurrent Non-Hodgkin Lymphomas, Chronic Lymphocytic Leukemia, or B-Cell Prolymphocytic Leukemia

Who this might be right for
B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin LymphomaB-Cell Prolymphocytic LeukemiaHigh Grade B-Cell Lymphoma, Not Otherwise Specified+10 more
City of Hope Medical Center 37
Large-scale testing (Phase 3)Study completedNCT01287260
What this trial is testing

High Dose BAYA1040_Nifedipine: a Dose-comparative Study

Who this might be right for
Hypertension
Bayer 352
Post-approval studies (Phase 4)Ended earlyNCT02534155
What this trial is testing

High and Intermediate Risk Degenerative Mitral Regurgitation Treatment: A Trial Comparing MitraClip® to Surgical Therapy

Who this might be right for
Mitral Valve Insufficiency
University of Zurich 294
Not applicableStudy completedNCT05110404
What this trial is testing

COMPARISON BETWEEN TWO SUB-TYPES OF HIGH INTENSITY INTERVAL TRAINING

Who this might be right for
Diabetes Mellitus
Cairo University 72
Testing effectiveness (Phase 2)Study completedNCT03124433
What this trial is testing

Neoadjuvant Apalutamide (ARN509) and Radical Prostatectomy in Treatment of Intermediate to High Risk Prostate Cancer

Who this might be right for
Cancer of the Prostate
Singapore General Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT05450029
What this trial is testing

Neoadjuvant Chemoradiotherapy Plus Sintilimab for Intermediate/High Immunoscore Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Yanhong Deng 51
Testing effectiveness (Phase 2)UnknownNCT02572492
What this trial is testing

Study of Carfilzomib in Multiple Myeloma Relapsed After High-dose Melphalan With Autologous Stem Cell Support

Who this might be right for
Multiple Myeloma
Henrik Gregersen 200
Not applicableStudy completedNCT00282711
What this trial is testing

The WOMEN Study: What is the Optimal Method for Ischemia Evaluation in WomeN?

Who this might be right for
Coronary Artery DiseaseHeart DiseaseCoronary Arteriosclerosis+2 more
Hartford Hospital 824
Testing effectiveness (Phase 2)Study completedNCT00932412
What this trial is testing

The CLARA Study From the Acute Leukemia French Association (ALFA 0702 Trial)

Who this might be right for
Acute Myeloid Leukemia
Hospices Civils de Lyon 735
Not applicableTemporarily pausedNCT06144619
What this trial is testing

Non-Invasive Biomarkers in Prostate Cancer Disease Management

Who this might be right for
Prostate Cancer
H. Lee Moffitt Cancer Center and Research Institute 500
Not applicableActive Not RecruitingNCT01817192
What this trial is testing

Adjuvant Chemotherapy in Patients With Intermediate or High Risk Stage I or Stage IIA Non-squamous Non-Small Cell Lung Cancer: AIM-HIGH (Adjuvant Intervention in Molecular High Risk Patients)

Who this might be right for
Non-Small Cell Lung Cancer
Razor Genomics 420
Not applicableEnded earlyNCT05192837
What this trial is testing

Preoperative Smoking Cessation in Patients Undergoing Surgery

Who this might be right for
Smoking CessationSmoking ReductionSurgery--Complications+10 more
Luzerner Kantonsspital 251
Not applicableUnknownNCT04710953
What this trial is testing

Comparison of CPAP and Gamow Bag Ventilation to Treat HAPE

Who this might be right for
High Altitude Pulmonary Edema
sultan mehmood kamran 30
Not applicableLooking for participantsNCT06220045
What this trial is testing

Comparing PP and PVDF Meshes in Midline Laparotomy Closure for High-risk Colorectal Surgery. Impact on Incisional Hernia and Surgical Wound Infection.

Who this might be right for
Colorectal CancerWound InfectionHernia Incisional
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta 60
Post-approval studies (Phase 4)Active Not RecruitingNCT06627530
What this trial is testing

COACTION Trial - COmbination Androgen bloCkade in inTermediate to hIgh-risk prOstate caNcer

Who this might be right for
Prostate Cancer
Brazilian Clinical Research Institute 144
Testing effectiveness (Phase 2)Looking for participantsNCT06678126
What this trial is testing

Adaptive Versus Non-adaptive Radiotherapy and 2 Bladder Filling Instructions for Patients With Intermediate or High Risk Localized Prostate Cancer (ARP)

Who this might be right for
Prostate Cancer
Scott Tyldesley 104
Not applicableStudy completedNCT00561379
What this trial is testing

Diffuse Large B Cell Lymphoma of the Adult: Randomization Between High Dose Chemotherapy With Rituximab and CHOP 14-Rituximab

Who this might be right for
Lymphoma, Large-Cell, Diffuse
Nantes University Hospital 350
Not applicableStudy completedNCT07421310
What this trial is testing

COMPARISON BETWEEN LAPAROSCOPIC TRACTION (SHEHATA TECHNIQUE) AND 2-STAGE FOWLER STEPHENS ORCHIOPEXY FOR HIGH INTRABDOMINAL UNDESCENDED TESTIS. A PROSPECTIVE RANDOMIZED STUDY.

Who this might be right for
High Intrabdominal Undescended Testis
Ain Shams University 50
Early research (Phase 1)Ended earlyNCT06388759
What this trial is testing

TQ05105 Tablet for Myelofibrosis Treatment in Ruxolitinib-Resistant or Intolerant Patients

Who this might be right for
Myelofibrosis
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 9
Testing effectiveness (Phase 2)Study completedNCT03836066
What this trial is testing

Atezolizumab Plus Bevacizumab in First Line NSCLC Patients

Who this might be right for
Non Small Cell Lung Cancer
Fundación GECP 41
Next Page